Received Apr 21, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (NOVAVAX)) | NOVAVAX | 1 | 6024mf016a | IM / OT |
Site: Swelling at Injection Site-Mild, Systemic: Abdominal Pain-Medium, Systemic: Body Aches Generalized-Medium, Systemic: Dizziness / Lightheadness-Severe, Systemic: Exhaustion / Lethargy-Severe, Systemic: Headache-Medium, Systemic: Shakiness-Medium, Systemic: Vomiting-Medium, Systemic: Weakness-Severe, Additional Details: has been suffering from long covid before and after vaccine
antihistamine caused rash - unsure of product name